Page 3 - Fernando Marques News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Article content BRASILIA — The Brazilian pharmaceutical company that plans to produce Russia’s Sputnik V coronavirus vaccine will start making it next week even before health regulator Anvisa gives approval for use in Brazil, the company’s chief executive said on Friday. União Quimica’s facility in São Paulo has been certified by Anvisa for good production practices and the vaccine will be made for export to countries that have approved it, said CEO and founder Fernando Marques. We apologize, but this video has failed to load. Try refreshing your browser, or Brazilian firm to produ...

RIO DE JANEIRO, May 7. /TASS/. Uniao Quimica will start producing the Sputnik V coronavirus vaccine in Brazil before the national regulator (Anvisa) gives its approval, CEO of the Brazilian pharmaceutical company Fernando Marques said on Friday. "We will get a batch of the active component from Moscow next week and will start bottling the vaccine at the plant in Guarulhos," he said. "We will start production immediately after receiving components and will await registration enabling us to start its use in the country," Marques noted. Production of the active component in Brazil is to start a...

Brazilian official lashes at watchdog for its decision on Sputnik V According to Vilas-Boas, the watchdog’s refusal to authorize imports of the Russian vaccine is unjustified RIO DE JANIERO, April 28. /TASS/. The Brazilian Health Regulatory Agency (Anvisa), which refused to authorize imports of Russia’s Sputnik V anti-coronavirus vaccine, has completely ignored the real epidemiological situation in the country, the chief healthcare official of Brazil’s state of Bahia, Fabio Vilas-Boas, said on Tuesday. "In our joint opinion with [local pharmaceutical company] BahiaPharma, Anvisa will...

Brazil’s regulator not allowing Sputnik V’s import due to political reasons - developers The delay by Anvisa to issue permission for the import and use of the Sputnik V vaccine has nothing to do with access to data on the vaccine or science, the vaccine’s Twitter account said MOSCOW, April 27. /TASS/. Developers of Russia’s Sputnik V COVID-19 vaccine believe that the refusal of the Brazilian Health Regulatory Agency (Anvisa) to allow its import is politically motivated, the vaccine’s Twitter account said. "The delay by the Brazilian Health Regulatory Agency (Anvisa) to issu...

Brazil’s scientists recognize Russia’s Sputnik V vaccine as safe According to Brazil’s legislation, the approval by the committee for biological safety is necessary for all drugs manufactured with the use of GMO technologies © Anton Novoderezhkin/TASS RIO DE JANEIRO, April 27. /TASS/. Members of a scientific and technical committee for biological safety at Brazil’s Ministry of Science, Technology and Innovation (MCTI) have recognized Russia’s Sputnik V COVID-19 vaccine as safe, the committee’s head, Paulo Barroso, said. "This is the third COVID-19 vaccine, which we are...